EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

EpCAM and its potential role in tumor-initiating cells

(2012) Sannia Imrich et al.   Cell Adhesion & Migration

Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

(2011) Carlo Patriarca et al.   CANCER TREATMENT REVIEWS

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

(2010) Markus M. Heiss et al.   INTERNATIONAL JOURNAL OF CANCER

Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

(2009) S. Lorenzen et al.   ANNALS OF ONCOLOGY

The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

(2009) M. Munz et al.   CANCER RESEARCH

Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers

(2008) Kunihiko Hiraiwa et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH

CD44 and EpCAM: Cancer-Initiating Cell Markers

(2008) Rachid Marhaba et al.   CURRENT MOLECULAR MEDICINE

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

(2008) Taro Yamashita et al.   GASTROENTEROLOGY